Latest MaRS Innovation Ventures Trust Stories
TORONTO AND SAN DIEGO, Jan.
A Unique Collaboration of Life Science Leaders, including the Fight Against Cancer Innovation Trust, MaRS Innovation Ventures Trust and MaRS Phase II Investment Trust, has formed Triphase Accelerator Corporation to be an Oncology Development Accelerator
Triphase Signs Collaboration and Option Agreement with a Leading Innovator of Cancer Therapies, Celgene Corporation TORONTO and SAN DIEGO, Jan.
Word of the Day
The word 'postliminy' comes from a Latin word meaning 'threshold'.